OSAKA, Japan and FLORHAM PARK, N.J. , May 23, 2016 /PRNewswire/ -- Shionogi today announced positive results from two identically-designed 12 week phase III studies (COMPOSE I and II) demonstrating consistent efficacy and safety of naldemedine in ... International Business Times, 4 days ago
Shionogi Release: Two Naldemedine Phase III Studies Show Consistent Improvement Of Opioid-Induced Constipation - BioSpace, 3 days ago
New and Generic Drug Approvals: Ponstel - U.S. Food and Drug Administration, 2 weeks ago
More from: Healio, Reuters UK...and 32 other sources
1 images for "Shionogi"
Shionogi made decision to stay away from expensive category CEO says in interview that ``partnerships are the way to go'' Across the pharmaceutical industry, companies have rushed towards medicines with sky-high prices -- making bets in ...Bloomberg, 1 month ago
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its HIV joint venture with Pfizer Inc and Shionogi Ltd, ViiV Healthcare, has extended the coverage of its existing licence agreement with the Medicines Patent Pool for dolutegravir to ...4 Traders, 1 month ago GlaxoSmithKline's ViiV Extends Licence Agreement For Dolutegravir London Stock Exchange, 1 month ago
Pragma Pharmaceuticals is pleased to announce that it has finalized the acquisition of the Keflex product line from Shionogi Inc. Keflex (Photo: Business Wire) Pragma is working toward launching later this moth with Fera Pharmaceuticals ...TMC Net, 1 month ago PRAGMA PHARMACEUTICALS : LLC Announces Acquisition of Keflex® 4 Traders, 1 month ago Pragma Pharmaceuticals Acquires Keflex Citybizlist, 1 month ago Pragma Pharmaceuticals LLC Announces Acquisition of Keflex Asian Hospital & Healthcare Management, 1 month ago
1 of 5 FEATURED COMPANIES Allergan Inc. Bionovo Foamix Pharmaceuticals Novo Nordisk A/S Pep-Tonic Medical Shionogi & Co. Ltd. MORE About Post-Menopausal Vaginal Atrophy Drugs Vaginal atrophy also known as atrophic vaginitis is defined ...Research and Markets, 1 month ago Global Opioid Induced Constipation (OIC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022 Research and Markets, 3 days ago Global Idiopathic Pulmonary Fibrosis 2016-2020 - Unmet Medical Needs Drives the Market - Research and Markets 4 Traders, 4 days ago Industry Overview on Global Flomoxef Sodium Consumption 2016 MyNewsDesk, 1 week ago
Form F-6EF - Registration of American Depository Receipt shares, immediately effective SEC Accession No. 0001193805-16-003117 Filing Date 2016-04-25 2016-04-25 16:30:12 Filing Date Changed 2016-04-25 Effectiveness Date 2016-04-25 ...SEC Filings, 1 month ago
The front of Shionogi's Ulesfia copay voucher.--Courtesy of the FDA Things are getting hairy for New Jersey-based pharma Shionogi and its head lice treatment Ulesfia. The FDA is chastising the company for putting out a copay coupon that talks ...FiercePharmaMarketing, 1 month ago FDA chastises Shionogi for misleading copay voucher BioPharma Dive, 1 month ago
SHIONOGI : Study Results from Shionogi & Co. Ltd. Broaden Understanding of Pain Management (Effect of spinal monoaminergic neuronal system dysfunction on...4 Traders, 1 month ago
Share this article: A Phase 3 trial previously demonstrated the efficacy of Naldemedine Shionogi announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for naldemedine 0.2mg once daily tablet for ...Monthly Prescribing Reference, 1 month ago
Posted May. 27, 2016 at 6:23 a.m. Published: 2016-05-27 06:23:23 Updated: 2016-05-27 06:23:23 Arrivo Related Blog Posts Site Search By JIM SHAMP, NCBiotech Writer Research Triangle Park, N.C. — Here they go again. A group ...Local Tech Wire, 20 hours ago
on your WebpageAdd Widget >Get your members hooked!